Figure 2From: Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant disease PET image after second (Panel A), third (Panel B) and fourth relapse (Panel C) as well as after BR treatment (Panel D). Back to article page